Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Letter from Jim Otteson to the ITC Chairman from the ITC

Do you guys not read the posts that bother you? The NDCA ruling does not legally have any binding effect on the ITC. The CAFC resolves differences. The ITC MAY choose to follow--it doesn't have to do so.

Share
New Message
Please login to post a reply